U.S. markets close in 1 hour 30 minutes
  • S&P 500

    3,833.90
    -36.39 (-0.94%)
     
  • Dow 30

    31,407.62
    +16.10 (+0.05%)
     
  • Nasdaq

    13,016.43
    -342.36 (-2.56%)
     
  • Russell 2000

    2,223.15
    -8.36 (-0.37%)
     
  • Crude Oil

    61.34
    +1.59 (+2.66%)
     
  • Gold

    1,714.00
    -19.60 (-1.13%)
     
  • Silver

    26.27
    -0.61 (-2.27%)
     
  • EUR/USD

    1.2070
    -0.0018 (-0.14%)
     
  • 10-Yr Bond

    1.4670
    +0.0520 (+3.67%)
     
  • GBP/USD

    1.3960
    +0.0003 (+0.02%)
     
  • USD/JPY

    106.9770
    +0.2670 (+0.25%)
     
  • BTC-USD

    50,528.91
    +2,647.64 (+5.53%)
     
  • CMC Crypto 200

    1,012.16
    +24.06 (+2.44%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Indonesia's Bio Farma says trials of Sinovac COVID-19 vaccine "going smoothly"

JAKARTA, Nov 10 (Reuters) - Indonesia's state-owned pharmaceutical company Bio Farma said on Tuesday that its clinical trials of China's Sinovac coronavirus vaccine were "going smoothly", after Brazil suspended trials due to a "severe adverse effect."

Edwin G. Pringadi, a spokesman for Bio Farma, said there were no plans to cancel the clinical trials, involving about 1,600 people in the Indonesian province of West Java.

Indonesia has confirmed 440,569 coronavirus infections and 14,614 deaths, the highest tolls in Southeast Asia.

(Reporting by Stanley Widianto Editing by Ed Davies)